Biotech

All Articles

AvenCell bags $112M to flip 'switchable' CAR-Ts in the center

.AvenCell Rehabs has protected $112 million in set B funds as the Novo Holdings-backed biotech finds...

China- based biotech plans ph. 3 after observing midstage eye information

.China-based Minghui Drug has actually connected its own thyroid eye ailment therapy to a decrease i...

Sangamo slashes time to market for Fabry gene treatment as FDA agrees to sped up approval package

.Sangamo Therapeutics has actually determined a quick way to market for its Fabry health condition c...

Otsuka's kidney condition medication boosts UPCR amounts in ph. 3 test

.Otsuka Pharmaceutical's renal health condition medication has hit the primary endpoint of a phase 3...

Roche tosses out $120M tau possibility, sending back civil liberties to UCB

.Roche has actually returned the liberties to UCB's anti-tau antibody bepranemab, ignoring a $120 mi...

Editas builds up in vivo method by means of $238M Genenvant pact

.Editas Medicines has signed a $238 million biobucks pact to integrate Genevant Science's crowd nano...

Combo outcomes, Vicodin overlook and also celestial safety and security

.Vertex has actually disclosed stage 3 information on its near-approval discomfort drug prospect suz...

Angelini markers $360M biobucks treaty for ph. 1 mind ailment medication

.Italy's Angelini Pharma has actually authorized a $360 thousand biobucks contract fixated a stage 1...

Sage gives up half of R&ampD group and also shocks C-suite once again

.Sage Rehabs' most up-to-date attempt to shrink its own pipeline and staff are going to see a third ...

With phase 1 information, Aura has an eye on early-stage sac cancer cells

.Along with its lead candidate in a phase 3 test for a rare eye cancer, Aura Biosciences is actually...